AI-powered clinical-stage drug discovery company MindRank announced raised over $20 million to advance the company's proprietary innovative drug pipeline and to refine and commercialize its AI platform.Hengrui Pharmaceuticals published study results for SHR-1707, its anti-β-amyloid (Aβ) monoclonal antibody (mAb) at this year’s Alzheimer's Association International Conference (AAIC).